Responses
Poster Presentation
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation
Compose a Response to This Article
Other responses
No responses have been published for this article.